Reported Standalone quarterly numbers for Cadila Healthcare are:
Net Sales at Rs 2,056.90 crore in September 2020 up 22.24% from Rs. 1,682.70 crore in September 2019.
Quarterly Net Profit at Rs. 473.00 crore in September 2020 down 24.67% from Rs. 627.90 crore in September 2019.
EBITDA stands at Rs. 688.40 crore in September 2020 down 21.21% from Rs. 873.70 crore in September 2019.
Cadila Health EPS has decreased to Rs. 4.62 in September 2020 from Rs. 6.13 in September 2019.
Cadila Health shares closed at 410.65 on November 02, 2020 (NSE) and has given 24.36% returns over the last 6 months and 69.94% over the last 12 months.
| Cadila Healthcare | | Standalone Quarterly Results | in Rs. Cr. |
|
| Sep'20 | Jun'20 | Sep'19 | | Net Sales/Income from operations | 2,056.90 | 1,795.90 | 1,567.30 | | Other Operating Income | -- | -- | 115.40 | | Total Income From Operations | 2,056.90 | 1,795.90 | 1,682.70 | | EXPENDITURE | | Consumption of Raw Materials | 603.70 | 520.50 | 480.30 | | Purchase of Traded Goods | 65.90 | 30.60 | 97.30 | | Increase/Decrease in Stocks | -16.60 | -66.30 | -84.10 | | Power & Fuel | -- | -- | -- | | Employees Cost | 278.00 | 292.80 | 267.30 | | Depreciation | 112.10 | 110.90 | 92.40 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 498.30 | 429.10 | 456.20 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 515.50 | 478.30 | 373.30 | | Other Income | 60.80 | 20.00 | 408.00 | | P/L Before Int., Excpt. Items & Tax | 576.30 | 498.30 | 781.30 | | Interest | 14.90 | 19.90 | 68.30 | | P/L Before Exceptional Items & Tax | 561.40 | 478.40 | 713.00 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 561.40 | 478.40 | 713.00 | | Tax | 88.40 | 80.20 | 85.10 | | P/L After Tax from Ordinary Activities | 473.00 | 398.20 | 627.90 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 473.00 | 398.20 | 627.90 | | Equity Share Capital | 102.40 | 102.40 | 102.40 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 4.62 | 3.89 | 6.13 | | Diluted EPS | 4.62 | 3.89 | 6.13 | | EPS After Extra Ordinary | | Basic EPS | 4.62 | 3.89 | 6.13 | | Diluted EPS | 4.62 | 3.89 | 6.13 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
